Back to RU Rubric Capital Management LP

TRVITRVI

Showing 8 of 18 quarters

Position history for RURubric Capital Management LP's holdings in Trevi Therapeutics, Inc.

No. Rubric Capital Management exited its TRVI (Trevi Therapeutics) position in Q3 2026. Its Q2 2026 13F listed 2,504,513 shares worth $46.7M. Rubric Capital Management first reported TRVI in Q2 2022 and held it in 17 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$17.3M

Total Shares Change

-4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$14.32
0
2026-Q2
Decreased
2.5M
-32.5%
$46.7M0.4%$18.65
0
2026-Q1
Decreased
3.7M
-1.4%
$44.3M0.5%$11.93
0
2025-Q4
Decreased
3.8M
-55.9%
$47.2M0.6%$12.52
0
2025-Q3
Unchanged
8.5M
0.0%
$78.1M0.9%$9.15
0
2025-Q2
Increased
8.5M
+88.0%
$46.7M0.7%$5.47
64
2025-Q1
Increased
4.5M
+7.9%
$28.5M0.5%$6.29
44
2024-Q4
Decreased
4.2M
-16.4%
$17.3M0.2%$4.12
0

Optional analytics helps us improve. How it’s used